Case Control Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2519-2526
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2519
Table 1 Demographic and preoperative clinical characteristics of 312 patients
VariablesNumber of patients
Age, median (range)66 (20-96)
Sex
Male233
Female79
Diabetes mellitus
Absent273
Present39
Cardiac comorbidities
Absent217
Present95
Pulmonary comorbidities
Absent292
Present20
Preoperative symptoms
Absent172
Present140
Preoperative body mass index, mean ± SD21.9 ± 3.2
Tumor location
Entire8
Upper third68
Middle third120
Lower third116
Tumor size (mm)
< 50176
≥ 50136
UICC cT factor
cT10
cT2150
cT395
cT467
UICC cN factor
cN0157
cN193
cN253
cN39
UICC clinical stage
IB98
IIA71
IIB69
IIIA55
IIIB14
IIIC5

  • Citation: Inaoka K, Kanda M, Uda H, Tanaka Y, Tanaka C, Kobayashi D, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer. World J Gastroenterol 2017; 23(14): 2519-2526
  • URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2519.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2519